{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:25:34Z","timestamp":1760955934201,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00234-019-02215-y","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T09:27:51Z","timestamp":1555579671000},"page":"775-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-5681","authenticated-orcid":false,"given":"Georg","family":"Bier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Klumpp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Roder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Preibsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Ernemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann-Martin","family":"Hempel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"2215_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(06)70443-4","volume":"5","author":"B Gleissner","year":"2006","unstructured":"Gleissner B, Chamberlain MC (2006) Neoplastic meningitis. Lancet Neurol 5:443\u2013452","journal-title":"Lancet Neurol"},{"key":"2215_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1102\/1470-7330.2009.9004","volume":"9","author":"G Mahendru","year":"2009","unstructured":"Mahendru G, Chong V (2009) Meninges in cancer imaging. Cancer Imaging 9:14\u201321","journal-title":"Cancer Imaging"},{"key":"2215_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/BF00343862","volume":"31","author":"MJ Taphoorn","year":"1989","unstructured":"Taphoorn MJ, Heimans JJ, Kaiser MC et al (1989) Imaging of brain metastases. Comparison of computerized tomography (CT) and magnetic resonance imaging (MRI). Neuroradiology 31:391\u2013395","journal-title":"Neuroradiology"},{"key":"2215_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/248072","volume":"2013","author":"P Pr\u00f6mmel","year":"2013","unstructured":"Pr\u00f6mmel P, Pilgram-Pastor S, Sitter H et al (2013) Neoplastic meningitis: how MRI and CSF cytology are influenced by CSF cell count and tumor type. Sci World J 2013:248072","journal-title":"Sci World J"},{"key":"2215_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW et al (1999) The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246:810\u2013814","journal-title":"J Neurol"},{"key":"2215_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1148\/rg.272065155","volume":"27","author":"JG Smirniotopoulos","year":"2007","unstructured":"Smirniotopoulos JG, Murphy FM, Rushing EJ, Rees JH, Schroeder JW (2007) Patterns of contrast enhancement in the brain and meninges. Radiographics 27:525\u2013551","journal-title":"Radiographics"},{"key":"2215_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejrad.2005.11.012","volume":"58","author":"H Parmar","year":"2006","unstructured":"Parmar H, Sitoh Y-Y, Anand P, Chua V, Hui F (2006) Contrast-enhanced flair imaging in the evaluation of infectious leptomeningeal diseases. Eur J Radiol 58:89\u201395","journal-title":"Eur J Radiol"},{"key":"2215_CR8","doi-asserted-by":"publisher","first-page":"557","DOI":"10.4103\/0973-1482.77070","volume":"6","author":"R Cosar-Alas","year":"2010","unstructured":"Cosar-Alas R, Alas A, Ozen A, Denizli B, Saynak M, Uzunoglu S, Aydogdu N, Karagol H, Uzal C, Kocak Z (2010) Capecitabine-related intracranial hypotension syndrome mimicking dural metastasis in a breast cancer patient: case report and review of the literature. J Cancer Res Ther 6:557\u2013559","journal-title":"J Cancer Res Ther"},{"key":"2215_CR9","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.3174\/ajnr.A4581","volume":"36","author":"S Ali","year":"2015","unstructured":"Ali S, Lee S-K (2015) Ipilimumab therapy for melanoma: a mimic of leptomeningeal metastases. AJNR Am J Neuroradiol 36:E69\u2013E70","journal-title":"AJNR Am J Neuroradiol"},{"key":"2215_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/mus.23830","volume":"48","author":"G Manousakis","year":"2013","unstructured":"Manousakis G, Koch J, Sommerville RB, el-Dokla A, Harms MB, al-Lozi MT, Schmidt RE, Pestronk A (2013) Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve 48:440\u2013444","journal-title":"Muscle Nerve"},{"key":"2215_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/BF00588709","volume":"35","author":"M Watanabe","year":"1993","unstructured":"Watanabe M, Tanaka R, Takeda N (1993) Correlation of MRI and clinical features in meningeal carcinomatosis. Neuroradiology 35:512\u2013515","journal-title":"Neuroradiology"},{"key":"2215_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijrobp.2008.03.056","volume":"73","author":"JA Muscal","year":"2009","unstructured":"Muscal JA, Jones JY, Paulino AC, Bertuch AA, Su J, Woo SY, Mahoney DH Jr, Chintagumpala M (2009) Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys 73:214\u2013221","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2215_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuonc\/now197","volume":"19","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Junck L, Brandsma D, Soffietti R, Rud\u00e0 R, Raizer J, Boogerd W, Taillibert S, Groves MD, le Rhun E, Walker J, van den Bent M, Wen PY, Jaeckle KA (2017) Leptomeningeal metastases: A RANO proposal for response criteria. Neuro-oncology 19:484\u2013492","journal-title":"Neuro-oncology"},{"key":"2215_CR14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10143-015-0646-y","volume":"38","author":"J Antony","year":"2015","unstructured":"Antony J, Hacking C, Jeffree RL (2015) Pachymeningeal enhancement-a comprehensive review of literature. Neurosurg Rev 38:649\u2013659","journal-title":"Neurosurg Rev"},{"key":"2215_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"2215_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00234-008-0445-z","volume":"50","author":"R Forghani","year":"2008","unstructured":"Forghani R, Farb RI (2008) Diagnosis and temporal evolution of signs of intracranial hypotension on MRI of the brain. Neuroradiology 50:1025\u20131034","journal-title":"Neuroradiology"},{"key":"2215_CR17","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/art.24577","volume":"60","author":"L Schmid","year":"2009","unstructured":"Schmid L, M\u00fcller M, Treumann T, Arnold W, M\u00f6ller B, Aeberli D, Villiger PM (2009) Induction of complete and sustained remission of rheumatoid pachymeningitis by rituximab. Arthritis Rheum 60:1632\u20131634","journal-title":"Arthritis Rheum"},{"key":"2215_CR18","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","volume":"18","author":"L Seymour","year":"2017","unstructured":"Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Liti\u00e8re S, Dancey J, Chen A, Hodi FS, Therasse P, Hoekstra OS, Shankar LK, Wolchok JD, Ballinger M, Caramella C, de Vries EG, RECIST working group (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18:e143\u2013e152","journal-title":"Lancet Oncol"},{"key":"2215_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrendo.2016.205","volume":"13","author":"DJ Byun","year":"2017","unstructured":"Byun DJ, Wolchok JD, Rosenberg LM, Girotra M (2017) Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies. Nat Rev Endocrinol 13:195\u2013207","journal-title":"Nat Rev Endocrinol"},{"key":"2215_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.annemergmed.2018.04.019","volume":"73","author":"I Majzoub El","year":"2018","unstructured":"El Majzoub I, Qdaisat A, Thein KZ et al (2018) Adverse effects of immune checkpoint therapy in Cancer patients visiting the emergency Department of a Comprehensive Cancer Center. Ann Emerg Med 73:79\u201387","journal-title":"Ann Emerg Med"},{"key":"2215_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.autrev.2018.01.003","volume":"17","author":"M Lidar","year":"2018","unstructured":"Lidar M, Giat E, Garelick D, Horowitz Y, Amital H, Steinberg-Silman Y, Schachter J, Shapira-Frommer R, Markel G (2018) Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors. Autoimmun Rev 17:284\u2013289","journal-title":"Autoimmun Rev"},{"key":"2215_CR22","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/annonc\/mdx286","volume":"28","author":"L Khoja","year":"2017","unstructured":"Khoja L, Day D, Wei-Wu Chen T, Siu LL, Hansen AR (2017) Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review. Ann Oncol 28:2377\u20132385","journal-title":"Ann Oncol"},{"key":"2215_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12254-018-0389-x","volume":"11","author":"L Beer","year":"2018","unstructured":"Beer L, Hochmair M, Prosch H (2018) Pitfalls in the radiological response assessment of immunotherapy. Memo 11:138\u2013143","journal-title":"Memo"},{"key":"2215_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/pcmr.12503","volume":"29","author":"BY Kong","year":"2016","unstructured":"Kong BY, Menzies AM, Saunders CAB, Liniker E, Ramanujam S, Guminski A, Kefford RF, Long GV, Carlino MS (2016) Residual FDG-PET metabolic activity in metastatic melanoma patients with prolonged response to anti-PD-1 therapy. Pigment Cell Melanoma Res 29:572\u2013577","journal-title":"Pigment Cell Melanoma Res"},{"key":"2215_CR25","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00415-010-5892-x","volume":"258","author":"JP Kerklaan","year":"2011","unstructured":"Kerklaan JP, Lycklama \u00e1 Nijeholt GJ, Wiggenraad RGJ, Berghuis B, Postma TJ, Taphoorn MJB (2011) SMART syndrome: a late reversible complication after radiation therapy for brain tumours. J Neurol 258:1098\u20131104","journal-title":"J Neurol"},{"key":"2215_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1212\/01.wnl.0000228862.76269.62","volume":"67","author":"A Pruitt","year":"2006","unstructured":"Pruitt A, Dalmau J, Detre J, Alavi A, Rosenfeld MR (2006) Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology 67:676\u2013678","journal-title":"Neurology"},{"key":"2215_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neuro-Oncol 9:225\u2013229","journal-title":"J Neuro-Oncol"},{"key":"2215_CR28","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759\u2013772","journal-title":"Cancer"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-019-02215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00234-019-02215-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-019-02215-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T23:23:50Z","timestamp":1587079430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00234-019-02215-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,18]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2215"],"URL":"https:\/\/doi.org\/10.1007\/s00234-019-02215-y","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"type":"print","value":"0028-3940"},{"type":"electronic","value":"1432-1920"}],"subject":[],"published":{"date-parts":[[2019,4,18]]},"assertion":[{"value":"19 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standard. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Our local ethics committee waived the requirement to obtain informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}